A 52-year-old man with a 15-year history of alcohol use disorder presents with jaundice, ascites, and spider angiomas. Clinical examination reveals hepatomegaly and splenomegaly. Serum bilirubin is 4.2 mg/dL, AST 120 U/L, ALT 65 U/L, and albumin 2.8 g/dL. Which investigation is most appropriate to confirm the diagnosis of cirrhosis and assess its etiology?

## Diagnosis of Cirrhosis: Gold Standard Investigation **Key Point:** Liver biopsy with histopathology remains the gold standard for confirming cirrhosis and determining its etiology, despite advances in non-invasive imaging. ### Why Liver Biopsy Is Superior in This Case 1. **Histological confirmation**: Biopsy directly visualizes bridging fibrosis, regenerative nodules, and architectural distortion — the hallmark of cirrhosis. 2. **Etiology determination**: Allows assessment for: - Steatosis (alcohol-related liver disease) - Inflammation and necrosis patterns - Presence of Mallory-Denk bodies (alcoholic cirrhosis) - Iron deposition (hemochromatosis) - Viral inclusions or markers 3. **Grading and staging**: Provides precise histological grade and stage, which guides prognosis and treatment decisions. ### Non-Invasive Alternatives and Their Limitations | Investigation | Utility | Limitation | |---|---|---| | **Transient elastography** | Assesses liver stiffness; good for screening fibrosis | Cannot determine etiology; operator-dependent; unreliable in ascites/obesity | | **CT abdomen** | Detects cirrhotic features (nodular liver, ascites, portal hypertension signs) | Does not confirm cirrhosis histologically; cannot assess etiology; radiation exposure | | **PT/INR** | Reflects synthetic function; prognostic marker | Non-specific; reflects severity but not diagnosis | **Clinical Pearl:** Although transient elastography is increasingly used for non-invasive fibrosis assessment, it cannot replace biopsy when etiology confirmation is critical — especially in alcoholic liver disease where histological features (Mallory-Denk bodies, neutrophilic infiltration) guide diagnosis and counseling. **High-Yield:** In a patient with clinical signs of cirrhosis and biochemical evidence of hepatic dysfunction, liver biopsy remains indicated when: - Etiology is unclear - Staging is needed for prognostication - Treatment decisions depend on histological confirmation **Tip:** Remember the clinical context — this patient has a clear history of alcohol use and clinical stigmata of cirrhosis. Biopsy confirms the diagnosis and rules out concurrent conditions (HCV, autoimmune hepatitis, hemochromatosis) that may require specific therapy.